Benefits Of Screening Women For Diabetes After Delivery Capstone Project

PAGES
6
WORDS
1924
Cite
Related Topics:

SYNTHESIS
Gestational diabetes mellitus (GDM), glucose intolerance recognized during pregnancy, affects approximately 7% of all pregnancies in the United States. GDM, diagnosed by an abnormal oral glucose tolerance test (OGTT) done during the second trimester. Women diagnosed with GDM are at a high risk of developing type 2 diabetes, cardiovascular disease, and hypertension. With this prevalence, the American Diabetes Association (ADA) has recommended screening women with GDM 6-12 weeks after delivery, which roughly coincides with the timing of their first postpartum visit. For almost 90% of women diagnosed with GDM, glucose intolerance will resolve immediately after delivery, but their risk of developing type 2 diabetes mellitus is 35% to 60%. There is also a likelihood of the woman adversely affecting their future offspring when they become pregnant again with undiagnosed type 2 diabetes mellitus or they experience recurrent GDM. There is a need to analyze the factors contributing to and hinder women's screening during their postpartum visit. The literature review will be structured using identified variables to focus on the barriers, attitude, knowledge and awareness, and postpartum screening visits. These themes will establish the importance of screening for GDM during the postpartum visit and its impact on compliance with healthcare.

Synthesis of Literature

Postpartum Screening Visits

A majority of new mothers will not miss out on their first postpartum visit, which would be the opportune time for them to undergo GDM screening. As posited by Bandyopadhyay, Small, and Davey (2015), many women are aware of the risks and perceived inevitability of developing type 2 diabetes. Hence, they would be willing to present themselves for GDM screening during their 6-week postpartum visit. However, as Cho et al. (2015) noted, 51% of women who had been diagnosed with GDM failed to return to complete their postpartum glucose testing. Therefore, there is a need to determine the reasons for these high noncompliance numbers and determine ways of increasing compliance (Korpi-Hyövälti et al., 2012). Carson et al. (2015) established one of the reasons for noncompliance was directing the women to undergo testing at an outside laboratory instead of the same hospital where they are undergoing their postpartum visit. Having the women going to an outside laboratory becomes hectic, and most women will not present to the laboratory due to the time-consuming nature of the process. Considering the recommended screening time for GDM by the ADA is an arbitrary endpoint. Women diagnosed with GDM can be screened immediately after delivery and before their discharge as a way of increasing compliance with postpartum testing (Carter et al., 2018). Early testing increases the rates of tested women since the patients are relaxed and still in the hospital. With the initial postpartum OGTT results, patients can be informed of their abnormal results early, which would encourage them to come for their follow-up test during their first postpartum visit (Sunny et al., 2020).

Knowledge and Awareness

The underlying reason for the low numbers of women who return for GDM screening is the lack of knowledge and awareness. When the women are first diagnosed with GDM during their pregnancy, the physician will inform them of the need for a follow-up test after delivery (Carter et al., 2018). However, the way...…baby or going to the clinic with the baby and staying there for those extended periods was not favorable for most women (Sunny et al., 2020). The women have to choose between their health and caring for their young baby. In most cases, the women will opt to postpone the test, which results in them never taking the test as they continue to lack the time. Physicians have been a barrier too, numerous women have visited clinics multiple times, having been diagnosed with GDM, and they still did not get the test (Rosenbloom & Blanchard, 2018). Bandyopadhyay et al. (2015) found the physician's lack of information or the failure to hand over patient records to be the underlying cause of this issue. Korpi-Hyövälti et al. (2012) added communication needs to be improved between primary care physicians and obstetrics and gynecology care providers, ensuring patient information is appropriately shared and follow-up done.

New mothers feel overwhelmed by the baby, especially if they do not receive any support from family members. In most cases, the women did not have someone to leave the baby with, and the healthcare facility did not have baby care services (Cho et al., 2015). Mothers had to stay with the baby for the test's duration, which prevented many mothers from doing the test (Shah et al., 2011). The lack of assistance for the mothers in caring for the baby when they go for the test is a hindrance that echoed by Bandyopadhyay et al. (2015). Without any assistance or someone to leave the baby with, mothers get overwhelmed, preferring the comfort of their homes, instead,…

Sources Used in Documents:

References

Bandyopadhyay, M., Small, R., & Davey, M.-A. (2015). Attendance for postpartum glucose tolerance testing following gestational diabetes among South Asian women in Australia: A qualitative study. J Womens Health Issues Care, 4(1), 1-8.

Carson, M. P., Morgan, B., Gussman, D., Brown, M., Rothenberg, K., & Wisner, T. A. (2015). SUGAR: spotting undiagnosed glucose abnormal results—a new protocol to increase postpartum testing among women with gestational diabetes mellitus. American journal of perinatology, 32(03), 299-306.

Carter, E. B., Martin, S., Temming, L., Colditz, G., Macones, G. A., & Tuuli, M. G. (2018). Early versus 6–12 week postpartum glucose tolerance testing for women with gestational diabetes. Journal of Perinatology, 38(2), 118-121.

Cho, G. J., An, J.-J., Choi, S.-J., Oh, S.-y., Kwon, H.-S., Hong, S.-C., & Kwon, J.-Y. (2015). Postpartum glucose testing rates following gestational diabetes mellitus and factors affecting testing non-compliance from four tertiary centers in Korea. Journal of Korean medical science, 30(12), 1841-1846.

Korpi-Hyövälti, E., Laaksonen, D. E., Schwab, U., Heinonen, S., & Niskanen, L. (2012). How can we increase postpartum glucose screening in women at high risk for gestational diabetes mellitus? International journal of endocrinology, 2012.

Man, B. (2016). Diabetes Screening in US Women with a History of Gestational Diabetes. Division of Epidemiology and Biostatistics Michelle A. Kominiarek ….

Rosenbloom, J. I., & Blanchard, M. H. (2018). Compliance with postpartum diabetes screening recommendations for patients with gestational diabetes. Journal of women's health, 27(4), 498-502.

Shah, B., Lipscombe, L., Feig, D., & Lowe, J. (2011). Missed opportunities for type 2 diabetes testing following gestational diabetes: a population?based cohort study. BJOG: An International Journal of Obstetrics & Gynaecology, 118(12), 1484-1490.


Cite this Document:

"Benefits Of Screening Women For Diabetes After Delivery" (2020, November 18) Retrieved April 25, 2024, from
https://www.paperdue.com/essay/benefits-screening-women-for-diabetes-after-delivery-capstone-project-2175783

"Benefits Of Screening Women For Diabetes After Delivery" 18 November 2020. Web.25 April. 2024. <
https://www.paperdue.com/essay/benefits-screening-women-for-diabetes-after-delivery-capstone-project-2175783>

"Benefits Of Screening Women For Diabetes After Delivery", 18 November 2020, Accessed.25 April. 2024,
https://www.paperdue.com/essay/benefits-screening-women-for-diabetes-after-delivery-capstone-project-2175783

Related Documents

Gestational Diabetes and African-American Women Comment by Sabina: Gestational Diabetes is a diagnosis of diabetes during pregnancy. This diagnosis is usually obtained about the 24th week of pregnancy after taking a blood glucose test. A diagnosis of gestational diabetes does not mean the individual is going to become diabetic after pregnancy or was diabetic prior to pregnancy. Gestational diabetes is usually caused by the imbalance of hormones during pregnancy, along with other

Gestational Diabetes Mellitus: Implications for Pre-Screening and Type II Diabetes Gestational Diabetes Mellitus Implications for Pre-Screening in Type II Screening of patients for the condition of "gestational diabetes mellitus" is considered to be an extravagance from the perspective of Lepercq (2004) who considered Universal Screening to be "contentious." However due to the 6.4% mortality rate due to untreated diabetes mellitus as well as the know birth defects and maternal health effects there are those

Gestational Diabetes Case Study Subjective State the patient's chief complaint, reason for visit and/or the problem for which you are providing follow-up. The client is a 30-year-old 27 weeks pregnant Hispanic-American woman in her third pregnancy. The client is married and has two children living at home and no history of miscarriage. All symptoms related to the problem are described using the following cue descriptive categories: Precipitating/alleviating factors (including prescribed and/or self-remedies and their effect

Meta-AnalysesThe selected study (Dalenerolle et al., 2021) sought to determine whether race influenced the risk of gestational diabetes and related mental health disorders among ethnic minorities. The findings showed a sequelae of gestational diabetes with mental health disorders among minority ethnic groups, supporting the hypothesis that Asians, blacks, and other ethnic minorities are disproportionately affected (Dalenerolle et al., 2021).Dekkers (2018) defines a meta-analysis as a formal, quantitative study design in

Gestational Diabetes Amongst North American Pregnant Mothers: Responses Crowther, Hiller, Moss et al. (2005) show that "treatment of gestational diabetes reduces serious perinatal morbidity" -- more so than simple routine care, so that was an interesting discovery based on the questions posed by Nelson and Risa. The fact that gestational diabetes does affect both the mother and the embryo/fetus is indeed troubling -- and it got me thinking about how the

Another author notes, "African-American women are at an increased risk for developing gestational diabetes, experts say. Much like other forms of diabetes, gestational diabetes affects the way your body uses blood sugar (glucose). In the case of gestational diabetes, your blood-sugar level is too high" ("Exercise & pregnancy," 2006). Women suffering from gestational diabetes are also more prone to suffer from toxemia, as well. Another writer states, "Compared with